CDH2 and metastatic neoplasm: Increased expression of N-cadherin in non-metastatic, androgen-dependent PCa in animal model led to castration resistance, increased invasion and metastasis, which was consistent with findings showing elevated expression of N-cadherin in primary and metastatic tumors of patients with castration resistant PCa (CRPC) [24].